Lida Chu

About Lida

Lida Chu is a recognized commercial executive with proven success in the U.S. and Global biotechnology industry, and more than 20 years of experience in designing innovative commercial strategies for pharmaceutical and biotech companies. Lida’s broad experience in key pharmaceutical functional areas includes Marketing, Sales, Access & Reimbursement, Managed Care, Data Analytics, Market Research, Finance, and Law, in broad disease areas with a focus on Oncology over the past ~15 years.

Prior to starting her consulting career, Lida worked at Amgen for 20+ years and held multiple roles of increasing responsibility. Some of her positions include Executive Director, Global Marketing Lead for Kyprolis®, Executive Director and U.S. Brand Lead for three of Amgen’s flagship products in Oncology (Neulasta® Neupogen® and Aranesp®) with $5 Billion in net revenue, Executive Director and US Brand Lead for other oncology products including the launch of first oncolytic virus (Imlygic®). Lida also has extensive background in Access and Reimbursement and served as the Reimbursement, Access and Value lead for the Oncology Business Unit at Amgen.

During her tenure at Amgen, Lida was recognized with top awards, including Marketer of The Year, Brand of The Year, Brand Plan of the Year, Amgen’s Hall of Fame Award, Defining Amgen’s Destiny, and Future Leaders Award.

Lida attended the University of California, Los Angeles (UCLA) where she received a B.S. degree in Applied Mathematics and M.S. degree in Biostatistics, both with Magna Cum Laude. She also participated in an Amgen-sponsored executive Business Administration program with UCLA and Finance training program with the University of Southern California (USC).

Following graduate school, Lida worked at UCLA Medical Center and John Wayne Cancer Institute as a Statistician for Clinical Trial studies.

Lida is known for a unique blend of setting and executing commercial strategy and consistently advocating for the good patients. She currently serves as Co-Chair of Board of Directors for the local chapter of Cancer Support Community (CSC) and is passionate about ensuring patients and families have the support they need throughout their treatment journey.